Dexterra Group Inc.
HZNOF
$8.75
-$0.36-3.96%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 745.79M | 728.43M | 722.02M | 727.15M | 732.12M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 745.79M | 728.43M | 722.02M | 727.15M | 732.12M |
| Cost of Revenue | 612.07M | 603.00M | 598.33M | 605.49M | 615.30M |
| Gross Profit | 133.72M | 125.43M | 123.69M | 121.67M | 116.81M |
| SG&A Expenses | 55.16M | 48.06M | 47.33M | 44.41M | 41.94M |
| Depreciation & Amortization | 30.32M | 28.49M | 27.06M | 26.34M | 25.68M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 697.55M | 679.56M | 672.72M | 676.24M | 682.92M |
| Operating Income | 48.24M | 48.87M | 49.30M | 50.91M | 49.20M |
| Income Before Tax | 39.24M | 41.79M | 42.39M | 42.49M | 39.09M |
| Income Tax Expenses | 9.97M | 12.42M | 12.63M | 12.38M | 11.70M |
| Earnings from Continuing Operations | 29.27 | 29.37 | 29.76 | 30.11 | 27.39 |
| Earnings from Discontinued Operations | -- | -477.90K | -4.65M | -6.90M | -12.84M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -231.10K | -215.80K | -168.60K | -164.30K | -162.30K |
| Net Income | 29.04M | 28.67M | 24.94M | 23.04M | 14.39M |
| EBIT | 48.24M | 48.87M | 49.30M | 50.91M | 49.20M |
| EBITDA | 69.81M | 70.82M | 69.82M | 70.71M | 69.72M |
| EPS Basic | 0.47 | 0.46 | 0.40 | 0.36 | 0.23 |
| Normalized Basic EPS | 0.41 | 0.42 | 0.42 | 0.41 | 0.38 |
| EPS Diluted | 0.46 | 0.46 | 0.40 | 0.36 | 0.23 |
| Normalized Diluted EPS | 0.40 | 0.42 | 0.41 | 0.41 | 0.38 |
| Average Basic Shares Outstanding | 249.69M | 251.11M | 252.89M | 254.67M | 256.07M |
| Average Diluted Shares Outstanding | 253.53M | 253.96M | 255.05M | 256.35M | 257.22M |
| Dividend Per Share | 0.27 | 0.26 | 0.25 | 0.25 | 0.26 |
| Payout Ratio | 55.87% | 54.97% | 63.81% | 69.73% | 113.90% |